{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T03:06:47Z","timestamp":1789960007049,"version":"4.0.1"},"reference-count":86,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jinf.2018.10.005","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:02:57Z","timestamp":1539648177000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Gut dysbiosis and paediatric Crohn's disease"],"prefix":"10.1016","volume":"78","author":[{"given":"Andrea","family":"Brusaferro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Cavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Farinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Cozzali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Principi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4103-2837","authenticated-orcid":false,"given":"Susanna","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2018.10.005_bib0001","doi-asserted-by":"crossref","first-page":"g6670","DOI":"10.1136\/bmj.g6670","article-title":"Crohn's disease","volume":"349","author":"Kalla","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jinf.2018.10.005_bib0002","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the infl ammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jinf.2018.10.005_bib0003","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/gut.2009.188383","article-title":"Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data","volume":"58","author":"Benchimol","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.jinf.2018.10.005_bib0004","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1440-1746.2003.02975.x","article-title":"Increasing incidence of Crohn's disease in Victorian children","volume":"18","author":"Phavichitr","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0005","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1053\/j.gastro.2008.06.081","article-title":"Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease","volume":"135","author":"Van Limbergen","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jinf.2018.10.005_bib0006","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/00365520802600961","article-title":"Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)","volume":"44","author":"Solberg","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0007","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.cgh.2007.09.002","article-title":"Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study","volume":"5","author":"Solberg","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0008","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/jpc.12685","article-title":"Crohn disease and ulcerative colitis in children: an update for 2014","volume":"51","author":"Lemberg","year":"2015","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.jinf.2018.10.005_bib0009","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(15)00465-1","article-title":"Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study","volume":"387","author":"Cleynen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2018.10.005_bib0010","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.dld.2014.02.016","article-title":"Autophagy genes variants and paediatric Crohn's disease phenotype: a single-centre experience","volume":"46","author":"Strisciuglio","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jinf.2018.10.005_bib0011","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrmicro3344","article-title":"The gut microbiota, bacterial metabolites and colorectal cancer","volume":"12","author":"Louis","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0012","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/1462-2920.13589","article-title":"Formation of propionate and butyrate by the human colonic microbiota","volume":"19","author":"Louis","year":"2017","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0013","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1079\/BJN20041150","article-title":"Contribution of acetate to butyrate formation by human faecal bacteria","volume":"91","author":"Duncan","year":"2004","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jinf.2018.10.005_bib0014","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1038\/ncomms4611","article-title":"The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism","volume":"5","author":"Frost","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jinf.2018.10.005_bib0015","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cell.2013.12.016","article-title":"Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits","volume":"156","author":"De Vadder","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jinf.2018.10.005_bib0016","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/gut.47.3.397","article-title":"Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease","volume":"47","author":"Segain","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.jinf.2018.10.005_bib0017","doi-asserted-by":"crossref","first-page":"e6759","DOI":"10.1371\/journal.pone.0006759","article-title":"Butyrate-induced transcriptional changes in human colonic mucosa","volume":"4","author":"Vanhoutvin","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2018.10.005_bib0018","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1089\/biores.2012.0223","article-title":"Butyrate histone deacetylase inhibitors","volume":"1","author":"Steliou","year":"2012","journal-title":"Biores Open Access"},{"key":"10.1016\/j.jinf.2018.10.005_bib0019","doi-asserted-by":"crossref","first-page":"1131s","DOI":"10.1093\/ajcn\/73.6.1131S","article-title":"Microbial modulation of innate defense: goblet cells and the intestinal mucus layer","volume":"73","author":"Deplancke","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jinf.2018.10.005_bib0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.smim.2006.10.002","article-title":"Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota","volume":"19","author":"Smith","year":"2007","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0021","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/intimm\/dxp095","article-title":"Regulatory T cells: how do they suppress immune responses?","volume":"21","author":"Sakaguchi","year":"2009","journal-title":"Int Immunol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0022","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1198469","article-title":"Induction of colonic regulatory T cells by indigenous Clostridium species","volume":"331","author":"Atarashi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jinf.2018.10.005_bib0023","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.immuni.2008.02.017","article-title":"Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces","volume":"28","author":"Rubtsov","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jinf.2018.10.005_bib0024","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.mib.2013.06.003","article-title":"Faecalibacterium prausnitzii and human intestinal health","volume":"16","author":"Miquel","year":"2013","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0025","doi-asserted-by":"crossref","first-page":"7582","DOI":"10.1128\/AEM.02006-15","article-title":"Mucosa-associated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease","volume":"81","author":"Lopez-Siles","year":"2015","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0026","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.4049\/jimmunol.174.6.3237","article-title":"Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells","volume":"174","author":"Di Giacinto","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0027","doi-asserted-by":"crossref","DOI":"10.1111\/imm.12950","article-title":"Segmented filamentous bacteria-induced immune responses: a balancing act between host protection and autoimmunity","author":"Flannigan","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.jinf.2018.10.005_bib0028","doi-asserted-by":"crossref","first-page":"E8141","DOI":"10.1073\/pnas.1617460113","article-title":"Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice","volume":"113","author":"Tan","year":"2016","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jinf.2018.10.005_bib0029","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11926-016-0614-8","article-title":"The microbiome: a revolution in treatment for rheumatic diseases?","volume":"18","author":"Rosenbaum","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jinf.2018.10.005_bib0030","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","article-title":"Diversity of the human intestinal microbial flora","volume":"308","author":"Eckburg","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jinf.2018.10.005_bib0031","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jinf.2016.09.010","article-title":"Gut microbiota and central nervous system development","volume":"73","author":"Principi","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2018.10.005_bib0032","first-page":"26050","article-title":"The composition of the gut microbiota throughout life, with an emphasis on early life","volume":"26","author":"Rodr\u00edguez","year":"2015","journal-title":"Microb Ecol Health Dis"},{"key":"10.1016\/j.jinf.2018.10.005_bib0033","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrgastro.2012.152","article-title":"The gut microbiota in IBD","volume":"9","author":"Manichanh","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0034","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/ibd.21319","article-title":"Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray","volume":"16","author":"Kang","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jinf.2018.10.005_bib0035","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/gut.2003.025403","article-title":"Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease","volume":"53","author":"Ott","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.jinf.2018.10.005_bib0036","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1136\/gut.2005.078824","article-title":"Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease","volume":"55","author":"Conte","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jinf.2018.10.005_bib0037","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/gut.2005.073817","article-title":"Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach","volume":"55","author":"Manichanh","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jinf.2018.10.005_bib0038","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.chom.2015.09.008","article-title":"Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn's disease","volume":"18","author":"Lewis","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jinf.2018.10.005_bib0039","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/ajg.2010.143","article-title":"Appraisal of the pediatric Crohn's disease activity index on four prospectively collected datasets: recommended cutoff values and clinimetric properties","volume":"105","author":"Turner","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13073-016-0331-y","article-title":"Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease","volume":"8","author":"Shaw","year":"2016","journal-title":"Genome Med"},{"key":"10.1016\/j.jinf.2018.10.005_bib0041","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1097\/MIB.0000000000000776","article-title":"Mucosa-associated ileal microbiota in new-onset pediatric Crohn's disease","volume":"22","author":"Assa","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jinf.2018.10.005_bib0042","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1155\/2015\/509497","article-title":"Toward enteral nutrition in the treatment of pediatric Crohn's disease in Canada: a workshop to identify barriers and enablers","volume":"29","author":"Van Limbergen","year":"2015","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0043","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.crohns.2014.04.005","article-title":"Consensus guidelines of ECCO\/ESPGHAN on the medical management of pediatric Crohn's disease","volume":"8","author":"Ruemmele","year":"2014","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.jinf.2018.10.005_bib0044","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ecco-jcc\/jjx060","article-title":"Exclusive enteral nutrition therapy in paediatric Crohn's disease results in long-term avoidance of corticosteroids: results of a propensity-score matched cohort analysis","volume":"11","author":"Connors","year":"2017","journal-title":"J Crohn's Colitis"},{"issue":"5 Suppl","key":"10.1016\/j.jinf.2018.10.005_bib0045","first-page":"S29","article-title":"Enteral nutrition in inflammatory bowel disease of childhood","volume":"23","author":"Heuschkel","year":"1999","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"4Suppl","key":"10.1016\/j.jinf.2018.10.005_bib0046","first-page":"S184","article-title":"Enteral nutrition and microflora in pediatric Crohn's disease","volume":"29","author":"Lionetti","year":"2005","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.jinf.2018.10.005_bib0047","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1365-2036.2008.03796.x","article-title":"Sustained modulation of intestinal bacteria by exclusive enteral nutrition used to treat children with Crohn's disease","volume":"28","author":"Leach","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jinf.2018.10.005_bib0048","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.dld.2012.04.014","article-title":"Changes of faecal microbiota in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition","volume":"44","author":"Shiga","year":"2012","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jinf.2018.10.005_bib0049","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/MIB.0000000000000023","article-title":"Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition","volume":"20","author":"Gerasimidis","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jinf.2018.10.005_bib0050","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ajg.2013.46","article-title":"An altered gut microbiome profile in a child affected by Crohn's disease normalized after nutritional therapy","volume":"108","author":"D'Argenio","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0051","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.3109\/00365521.2012.703234","article-title":"Effect of exclusive enteral nutrition on gut microflora function in children with Crohn's disease","volume":"47","author":"Tjellstrom","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0052","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1038\/ajg.2015.357","article-title":"Extensive modulation of the fecal metagenome in children with Crohn's disease during exclusive enteral nutrition","volume":"110","author":"Quince","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0053","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/gutjnl-2015-311058","article-title":"Effects of enteral polymeric diet on gut microbiota in children with Crohn's disease","volume":"66","author":"Guinet-Charpentier","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jinf.2018.10.005_bib0054","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jaci.2015.12.1331","article-title":"Exclusive enteral nutrition in active pediatric Crohn disease: effects on intestinal microbiota and immune regulation","volume":"138","author":"Schwerd","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0055","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/ajg.2016.61","article-title":"Reduction in gut microbial diversity as a mechanism of action of exclusive enteral nutrition","volume":"111","author":"Kaakoush","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0056","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1097\/MIB.0000000000000949","article-title":"The gut microbiome of pediatric Crohn's disease patients differs from healthy controls in genes that can influence the balance between a healthy and dysregulated immune response","volume":"22","author":"Dunn","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jinf.2018.10.005_bib0057","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/MIB.0000000000000956","article-title":"Early changes in microbial community Structure are associated with sustained remission after nutritional treatment of pediatric Crohn's disease","volume":"22","author":"Dunn","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jinf.2018.10.005_bib0058","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/ajg.2015.149","article-title":"Fecal microbiota in pediatric inflammatory bowel disease and its relation to inflammation","volume":"110","author":"Kolho","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0059","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ecco-jcc\/jjx153","article-title":"Characteristics of faecal microbiota in paediatric Crohn's disease and their dynamic changes during infliximab therapy","volume":"12","author":"Wang","year":"2018","journal-title":"J Crohn's Colitis"},{"issue":"Suppl. 2","key":"10.1016\/j.jinf.2018.10.005_bib0060","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1017\/S0007114510003363","article-title":"Prebiotic effects: metabolic and health benefits","volume":"104","author":"Roberfroid","year":"2010","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jinf.2018.10.005_bib0061","doi-asserted-by":"crossref","first-page":"11505","DOI":"10.3748\/wjg.v20.i33.11505","article-title":"Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease","volume":"20","author":"Orel","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0062","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00253-012-4241-7","article-title":"Antioxidant properties of potentially probiotic bacteria: in vitro and in vivo activities","volume":"97","author":"Amaretti","year":"2013","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0063","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.nut.2011.08.013","article-title":"Probiotic yogurt improves antioxidant status in type 2 diabetic patients","volume":"28","author":"Ejtahed","year":"2012","journal-title":"Nutrition"},{"key":"10.1016\/j.jinf.2018.10.005_bib0064","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.yrtph.2015.09.021","article-title":"Antigenotoxic activity of lactic acid bacteria, prebiotics, and products of their fermentation against selected mutagens","volume":"73","author":"Nowak","year":"2015","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0065","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1021\/jf506326t","article-title":"Probiotics as potential antioxidants: a systematic review","volume":"63","author":"Mishra","year":"2015","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.jinf.2018.10.005_bib0066","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1007\/s11033-011-1269-1","article-title":"Anti-inflammatory and immunomodulatory efficacy of indigenous probiotic Lactobacillus plantarum Lp91 in colitis mouse model","volume":"39","author":"Duary","year":"2012","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.jinf.2018.10.005_bib0067","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8392523","article-title":"The interplay between defensins and microbiota in Crohn's disease","volume":"2017","author":"Coretti","year":"2017","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jinf.2018.10.005_bib0068","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2249.2007.03587.x","article-title":"Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2","volume":"151","author":"Schlee","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0069","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.anaerobe.2014.09.014","article-title":"The influence of Lactobacillus casei DN 114 001 on the activity of faecal enzymes and genotoxicity of faecal water in the presence of heterocyclic aromatic amines","volume":"30","author":"Nowak","year":"2014","journal-title":"Anaerobe"},{"key":"10.1016\/j.jinf.2018.10.005_bib0070","doi-asserted-by":"crossref","first-page":"25088","DOI":"10.1074\/jbc.M113.452516","article-title":"Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion","volume":"288","author":"Yadav","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jinf.2018.10.005_bib0071","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/gut.2005.074971","article-title":"Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease","volume":"55","author":"Lindsay","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jinf.2018.10.005_bib0072","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/gut.2010.232025","article-title":"Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease","volume":"60","author":"Benjamin","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jinf.2018.10.005_bib0073","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1440-1746.2010.06370.x","article-title":"Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome","volume":"25","author":"Ong","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0074","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.MIB.0000437495.30052.be","article-title":"Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials","volume":"20","author":"Shen","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jinf.2018.10.005_bib0075","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/01.MIB.0000175905.00212.2c","article-title":"A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease","volume":"11","author":"Bousvaros","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jinf.2018.10.005_bib0076","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/jcp.25911","article-title":"Probiotics are a good choice in remission of inflammatory bowel diseases: a meta-analysis and systematic review","volume":"233","author":"Ganji-Arjenaki","year":"2018","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0077","first-page":"209","article-title":"Fecal microbiota transplantation: from Clostridium difficile to inflammatory bowel disease","volume":"13","author":"Gianotti","year":"2017","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.jinf.2018.10.005_bib0078","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/ecco-jcc\/jjx063","article-title":"Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta-analysis","volume":"11","author":"Paramsothy","year":"2017","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jinf.2018.10.005_bib0079","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/MOG.0000000000000285","article-title":"Fecal transplantation: any real hope for inflammatory bowel disease?","volume":"32","author":"Moayyedi","year":"2016","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0080","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.3748\/wjg.v21.i17.5359","article-title":"Fecal microbiota transplantation as novel therapy in gastroenterology: a systematic review","volume":"21","author":"Rossen","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0081","doi-asserted-by":"crossref","first-page":"337\u2010341","DOI":"10.1126\/science.1198469","article-title":"Induction of colonic regulatory T cells by indigenous Clostridium species","volume":"331","author":"Atarashi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jinf.2018.10.005_bib0082","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cell.2015.08.058","article-title":"Th17 cell induction by adhesion of microbes to intestinal epithelial cells","volume":"163","author":"Atarashi","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jinf.2018.10.005_bib0083","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cgh.2011.08.014","article-title":"Treating Clostridium difficile infection with fecal microbiota transplantation","volume":"9","author":"Bakken","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jinf.2018.10.005_bib0084","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/ecco-jcc\/jjv203","article-title":"Donor species richness determines faecal microbiota transplantation success in inflammatory bowel disease","volume":"10","author":"Vermeire","year":"2016","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jinf.2018.10.005_bib0085","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1097\/MIB.0000000000000893","article-title":"Increased intestinal microbial diversity following fecal microbiota transplant for active Crohn's disease","volume":"22","author":"Vaughn","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jinf.2018.10.005_bib0086","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/MIB.0000000000000307","article-title":"Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease","volume":"21","author":"Suskind","year":"2015","journal-title":"Inflamm Bowel Dis"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445318303086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445318303086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:26:57Z","timestamp":1759008417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445318303086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0163445318303086"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2018.10.005","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut dysbiosis and paediatric Crohn's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2018.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}